I3 Capital Group

Institutional Active Dallas, United States Est. 2024
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
$1.5M
total disclosed, rounds participated
Stages
C Round, Debt Financing, Convertible Debt, F Round, D Round, G Round, E Round, B Round, PIPE, A Round

About

I3 Capital (formerly Arcstone Israel) is a division of a US FINRA and Canadian Exempt Market Dealer that is solely focused to providing Institutional quality Merchant, Investment Banking and Equity Research Services to Israeli Private and Public Market companies.

We help Israeli growth companies access North American capital markets with advisory services for investor marketing, fundraising, IPOs, mergers, and cross-border opportunities.

As part of a US and Canadian financial group, I3 Capital supports companies in using Canadian stock exchanges as a launchpad before expanding to the US.

We are registered with FMI Securities Inc. - FINRA - SIPC and Foundation Markets Inc. in Canada

Portfolio · 1

VVT Medical
Varicose Vein Treatment
Led ★ 1 round $1.5M committed Latest: 2025-07

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is I3 Capital Group's primary focus?
I3 Capital Group, formerly Arcstone Israel, focuses on providing institutional quality merchant, investment banking, and equity research services to Israeli private and public market companies. They assist these companies in accessing North American capital markets.
When was I3 Capital Group founded?
I3 Capital Group was founded in 2024.
Which investment stages does I3 Capital Group participate in?
I3 Capital Group participates in a range of investment stages including A, B, C, D, E, F, G Rounds, Convertible Debt, Debt Financing, and PIPE.
Who is a key member of I3 Capital Group's leadership team?
Oded Orgil is the President and a founder of I3 Capital Group.
Can you name a notable portfolio company for I3 Capital Group?
VVT Medical is a notable portfolio company of I3 Capital Group.
Has I3 Capital Group had any exits?
Yes, I3 Capital Group had an exit in July 2025 with VVT Medical through a Reverse Merger Event on the TSXV, with DXI Capital Corp. as the acquiring company.
What is I3 Capital Group's sector concentration?
I3 Capital Group shows a concentration in the Health Tech & Life Sciences sector, with one investment and one exit in this area.
What type of financial events has I3 Capital Group been involved in recently?
I3 Capital Group participated in a PIPE round in July 2025, which also marked a new portfolio company addition and an exit event in the same month.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)